On 22 June, Morse, Barnes-Brown & Pendleton (Waltham) hosted the second panel in their Life Sciences Series, Laying the Firm Foundation for Growth: Entity & Equity.The expert panel discussed whether a corporation or a limited liability company is more suitable for building an emerging company, and how to maximize the equity compensation of your team with restricted stock, stock options, or profits interests.MBBP Partner John Hession  moderated the panel, which included Marc Cote, Chief Operating Officer of Accellient, and Jeff Solomon, Partner at Katz Nannis + Solomon.[caption id="attachment_3422" align="alignleft" width="124"] John Hession[/caption]